BridgeMD
New treatment option for Ischemic Stroke
Official title Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group
ClinicalTrials.gov ID: NCT06728592
What this study is testing
- What it's testing
- Background Reperfusion therapies, i.e., intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT), are most effective treatments in the management of acute ischemic stroke (AIS) patients. The benefits of reperfusion therapies, however, may be reduced by treatment delays due to tests and examinations and logistic issues.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Age ≥18 years;
- Diagnosed as ischemic stroke;
- Potentially eligible for IVT and/or EVT and can be treated within 6 hours of symptom onset (time of symptom onset is defined as the last known normal...
- Presenting to AED during working hours (8AM to 6PM, weekdays);
- Written informed consent from patients or representatives, who understand Cantonese, to participate in this study.
You likely can't join if
- Patients with unstable vital signs who need urgent medical interventions/care;
- Confirmed contraindications for IVT or EVT by initial assessment (e.g., unstable vital signs, history of severe head trauma within 3 months, known...
- Claustrophobia or other conditions that are contraindicated for MRI;
- Patients with pacemakers, brain stimulators or insulin pumps;
- Patients with medical or other conditions that prevent cooperation with the procedures;
- Pregnant or breastfeeding women;
See the full eligibility criteria
- Age ≥18 years;
- Diagnosed as ischemic stroke;
- Potentially eligible for IVT and/or EVT and can be treated within 6 hours of symptom onset (time of symptom onset is defined as the last known normal time);
- Presenting to AED during working hours (8AM to 6PM, weekdays);
- Written informed consent from patients or representatives, who understand Cantonese, to participate in this study.
- Patients with unstable vital signs who need urgent medical interventions/care;
- Confirmed contraindications for IVT or EVT by initial assessment (e.g., unstable vital signs, history of severe head trauma within 3 months, known bleeding tendency), before starting brain imaging exams;
- Claustrophobia or other conditions that are contraindicated for MRI;
- Patients with pacemakers, brain stimulators or insulin pumps;
- Patients with medical or other conditions that prevent cooperation with the procedures;
- Pregnant or breastfeeding women;
- Participation in other clinical trials within 3 months before screening.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.